Back to search

Peptide record

TPDB42881

FHV-2D5 Anticancer standard
23 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB42881
FHV-2D5
Anticancer
Cancer-related peptides
CancerPPD 2.0
standard
No
A 23-aa standard natural anticancer peptide sequence curated from CancerPPD 2.0, with an available 3D structural model.
Sequence
RRRRNRTRRNRRRVRGGLTIYFY
Physicochemical Analysis
C130H224N58O30
ADCEQHKMPSW
R
3079.58
12.83
11
0
6
+11
6.24
-2.000
46.52
Mammalian: 1 hour Yeast: 2 min E.coli: 2 min
2980
96.77
6
Residue Composition
number
0
A
11
R
2
N
0
D
0
C
0
E
0
Q
2
G
0
H
1
I
1
L
0
K
0
M
1
F
0
P
0
S
2
T
0
W
2
Y
1
V
Amino Acid Distribution
A: 0 R: 11 N: 2 D: 0 C: 0 E: 0 Q: 0 G: 2 H: 0 I: 1 L: 1 K: 0 M: 0 F: 1 P: 0 S: 0 T: 2 W: 0 Y: 2 V: 1
Chemical Descriptors
23
C130H224N58O30
3079.58
12.83
+11
6.24
-2.000
Free
L
Linear
Free
Anticancer
STAP-2 PH domain–derived peptide
Evidence Records 1 records
Evidence 1 Activity

Activity

Graph figure 1-G
Anticancer

Target

Liver Cancer
DU-145
Liver

Assay & Model

CellTiter-Glo assay
48-h

Source & Reference

CancerPPD 2.0
CancerPPD2
2023

Other

Source Activity Label Source Definition
Anticancer
CancerPPD 2.0 manually curated experimentally verified anticancer peptide/protein annotation.